Monepantel

N/A

Report date: 2026/03/20 20:03:07
NME

Base Information

Drug NameMonepantel
Drug Alias NameS-MonepantelZolvixPPL-1NUZ-001
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCyclin-dependent kinase 2 modulatorsCyclin-dependent kinase 4 modulatorsTAR DNA binding protein 43 inhibitors +[4] 
TargetsCyclin-dependent kinase 4Cyclin-dependent kinase 2TAR DNA binding protein 43
Therapy Area/IndicationsMotor Neuron DiseaseAmyotrophic Lateral SclerosisNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesAustralia
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesPitney Pharmaceuticals Pty Ltd
China Registration ClassN/A

Develop Information

Active CompaniesNeurizon Therapeutics LtdPharmAust Ltd
Inactive CompaniesN/A
Active IndicationsMotor Neuron DiseaseAmyotrophic Lateral Sclerosis
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A